← All Sponsors
SPONSOR

University Hospital, Brest

Total Trials
13
Recruiting
13
Phases
Phase 2, Phase 3

University Hospital, Brest is a clinical research sponsor with 13 registered studies on ClinicalTrials.gov, of which 13 are actively recruiting participants. Research covers conditions including Systemic Lupus Erythematosus, Metabolic Myopathies, Exercise Test, Myalgia.

The trial portfolio spans Phase 2, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.

Frequently Asked Questions — University Hospital, Brest

How many clinical trials has University Hospital, Brest sponsored?
ClinicalMetric currently tracks 13 clinical trials sponsored by University Hospital, Brest, of which 13 are actively recruiting participants. These trials cover conditions including Systemic Lupus Erythematosus, Metabolic Myopathies, Exercise Test. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does University Hospital, Brest research focus on?
University Hospital, Brest clinical trials span Systemic Lupus Erythematosus, Metabolic Myopathies, Exercise Test, Myalgia, Autoimmune Diseases, and additional conditions. The research pipeline includes Phase 2, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a University Hospital, Brest clinical trial?
To participate in a University Hospital, Brest trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all University Hospital, Brest trials with current recruitment status updated daily.

Clinical Trials by University Hospital, Brest

NCT06551389
Recruiting

Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU

Systemic Lupus Erythematosus
NCT02362685
Recruiting

Metabolic Exercise Testing

Metabolic Myopathies
NCT04978948
Recruiting

Study of STIM1 Membrane Expression

Autoimmune Diseases
NCT05103670
Recruiting

Ventilation/Perfusion PET/CT With Galligas and 68Ga-MAA for Regional Lung Function Assessment After Pulmonary Embolism

Pulmonary Embolism
NCT05308888 Phase 2
Recruiting

Impact of Local Tissue Inflammation on Intramyocardial Conduction Pathways Post Percutaneous Valve : Evaluation by Positron Emission Tomography on Exploratory Cohort

Aortic Valve Stenosis
NCT06441773
Recruiting

Impact of Respiratory Rehabilitation on Quality of Life in Patients With Metastatic Non-small Cell Lung Cancer Treated With Immunotherapy and Chemotherapy in the Maintenance Phase

Cancer
NCT07280338
Recruiting

Emotional Intelligence and Chronic Orofacial Pain

Chronic Pain
NCT06372730
Recruiting

Residual Pulmonary Vascular Obstruction Index Computed With Ventilation/Perfusion SPECT/CT Imaging to Predict the Risk of Venous Thromboembolism Recurrence in Patients With Pulmonary Embolism (PRONOSPECT)

Pulmonary Embolism
NCT06894602
Recruiting

Association of Ultrasonographic Temporal Artery Lesions and Relapse in Patients With Giant Cell Arteritis

Giant Cell Arteritis
NCT05015153
Recruiting

Impact on Quality of Life With Pulmonary RehAbilitation After Pulmonary eMBOlism: RAMBO Study

Pulmonary Embolism
NCT05997979 Phase 3
Recruiting

Analgesic Effectiveness of Capsaicin 8% Cutaneous Patch in Children

Neuropathic Pain
NCT06365177
Recruiting

Evaluation of the Concordance of Five Times Sit To Stand Results Between a Physical Consultation and a Teleconsultation

Rehabilitation
NCT05384392
Recruiting

Biomarkers Predictive of Thymic Evolution and Therapeutic Response at 2 Years in Patients With a First Psychotic Episode

First-episode Psychosis
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology